UNSPSC 51384503: Benoxaprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H12ClNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 17SZX404IM, chemically known as 5-benzoxazoleacetic acid, 2-(4-chlorophenyl)-alpha-methyl, (+-)- but generally known as benoxaprofen, which bears US NIH Compound Identifier 39941. Benoxaprofen most often comes in base and glucuronide forms. European Medicines Agency schedules Benoxaprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05725MIG.

UNSPSC 51384503 Benoxaprofen is a Commodity code that nominally covers a specific nonsteroidal anti-inflammatory drug; however, the recent state and local procurement activity tagged under this code does not reflect pharmaceutical procurement aligned with the code's stated scope. The single recent opportunity on record — Seminole County, Florida's IFB for naloxone and drug deactivation systems — involves emergency-response pharmaceuticals and harm-reduction equipment entirely distinct from benoxaprofen. The mismatch suggests either a data-tagging error in the state or local procurement system or a deliberate administrative assignment that does not align with the code's nominal product definition. State and local purchasing offices occasionally use inconsistent or repurposed codes, and without additional opportunities under this Commodity code, it is not possible to characterize the actual procurement pattern or the kinds of issuing bodies regularly soliciting under it.

The geographic activity visible in the source is limited to Florida. Seminole County's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023, is the only recent opportunity recorded. The procurement is for 1,900 units of naloxone and 800 safe drug deactivation systems annually on a two-year initial term with a one-year renewal option, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Bidders must submit electronically, include all shipping and delivery costs, maintain specified insurance coverage, and satisfy E-Verify compliance and drug-free workplace certification. The opportunity offers no explicit set-aside designation for disadvantaged enterprises. Without additional recent opportunities across other jurisdictions, no meaningful assessment of activity volume, issuing-body diversity, or geographic concentration is possible under this code.